BLCM Annual CFF
$0.00
-$32.87 M-100.00%
31 December 2022
Summary:
As of February 5, 2025, BLCM annual cash flow from financing activities is $0.00, with the most recent change of -$32.87 million (-100.00%) on December 31, 2022. During the last 3 years, it has fallen by -$74.09 million (-100.00%).BLCM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM Quarterly CFF
N/A
01 September 2023
Summary:
BLCM quarterly cash flow from financing activities is not available.BLCM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM TTM CFF
N/A
01 September 2023
Summary:
BLCM TTM cash flow from financing activities is not available.BLCM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | - | - |
| 3 y3 years | -100.0% | - | - |
| 5 y5 years | -100.0% | - | - |
BLCM Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -100.0% |
Bellicum Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $0.00(-100.0%) | - | - |
| Dec 2021 | $32.87 M(-330.9%) | $32.91 M(>+9900.0%) | $32.87 M(-867.7%) |
| Sept 2021 | - | $0.00(-100.0%) | -$4.28 M(-0.5%) |
| June 2021 | - | -$15.00 K(-25.0%) | -$4.30 M(-64.8%) |
| Mar 2021 | - | -$20.00 K(-99.5%) | -$12.24 M(-14.0%) |
| Dec 2020 | -$14.24 M(-119.2%) | -$4.25 M(>+9900.0%) | -$14.24 M(+39.7%) |
| Sept 2020 | - | -$21.00 K(-99.7%) | -$10.19 M(-118.5%) |
| June 2020 | - | -$7.95 M(+294.3%) | $55.01 M(-18.4%) |
| Mar 2020 | - | -$2.02 M(+913.6%) | $67.38 M(-9.0%) |
| Dec 2019 | $74.09 M(+8.8%) | -$199.00 K(-100.3%) | $74.09 M(-0.8%) |
| Sept 2019 | - | $65.18 M(+1373.6%) | $74.66 M(+687.1%) |
| June 2019 | - | $4.42 M(-5.6%) | $9.48 M(-86.8%) |
| Mar 2019 | - | $4.69 M(+1159.9%) | $71.97 M(+5.7%) |
| Dec 2018 | $68.11 M(-13.2%) | $372.00 K(>+9900.0%) | $68.11 M(-2.9%) |
| Sept 2018 | - | $3000.00(-100.0%) | $70.13 M(-0.2%) |
| June 2018 | - | $66.91 M(+8050.2%) | $70.27 M(+1670.5%) |
| Mar 2018 | - | $821.00 K(-65.6%) | $3.97 M(-94.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $78.49 M(+275.0%) | $2.39 M(+1492.7%) | $78.49 M(+2.6%) |
| Sept 2017 | - | $150.00 K(-75.4%) | $76.48 M(-6.3%) |
| June 2017 | - | $609.00 K(-99.2%) | $81.61 M(+0.3%) |
| Mar 2017 | - | $75.34 M(>+9900.0%) | $81.36 M(+288.7%) |
| Dec 2016 | $20.93 M(+2458.4%) | $387.00 K(-92.7%) | $20.93 M(-0.0%) |
| Sept 2016 | - | $5.27 M(+1381.5%) | $20.93 M(+32.0%) |
| June 2016 | - | $356.00 K(-97.6%) | $15.85 M(+0.7%) |
| Mar 2016 | - | $14.91 M(+3733.2%) | $15.73 M(+1823.6%) |
| Dec 2015 | $818.00 K(-99.7%) | $389.00 K(+98.5%) | $818.00 K(-99.5%) |
| Sept 2015 | - | $196.00 K(-18.0%) | $180.65 M(-22.0%) |
| June 2015 | - | $239.00 K(-4083.3%) | $231.46 M(+0.1%) |
| Mar 2015 | - | -$6000.00(-100.0%) | $231.12 M(-3.1%) |
| Dec 2014 | $238.55 M(+1262.0%) | $180.22 M(+253.4%) | $238.55 M(+309.0%) |
| Sept 2014 | - | $51.00 M(<-9900.0%) | $58.32 M(+696.7%) |
| June 2014 | - | -$100.00 K(-101.3%) | $7.32 M(-1.3%) |
| Mar 2014 | - | $7.42 M | $7.42 M |
| Dec 2013 | $17.51 M(+398.2%) | - | - |
| Dec 2012 | $3.52 M | - | - |
FAQ
- What is Bellicum Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals annual CFF year-on-year change?
- What is the all time high quarterly CFF for Bellicum Pharmaceuticals?
- What is the all time high TTM CFF for Bellicum Pharmaceuticals?
What is Bellicum Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of BLCM is $0.00
What is the all time high annual CFF for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high annual cash flow from financing activities is $238.55 M
What is Bellicum Pharmaceuticals annual CFF year-on-year change?
Over the past year, BLCM annual cash flow from financing activities has changed by -$32.87 M (-100.00%)
What is the all time high quarterly CFF for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high quarterly cash flow from financing activities is $180.22 M
What is the all time high TTM CFF for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high TTM cash flow from financing activities is $238.55 M